All Stories

  1. Identifying hotspots of S. haematobium infection following praziquantel treatment during multiple annual mass drug administration campaigns in Zimbabwe
  2. Assessment of urine metabolite biomarkers for the detection of S. haematobium infection in pre-school aged children in a rural community in Zimbabwe
  3. Identification of Schistosoma haematobium and Schistosoma mansoni linear B-cell epitopes with diagnostic potential using in silico immunoinformatic tools and peptide microarray technology
  4. Transboundary COVID-19 response on health communication in Botswana, South Africa and Zimbabwe
  5. Plasma metabolite profiling for S. haematobium biomarkers of infection in pre-school aged children in Shamva District, Zimbabwe
  6. Identification ofSchistosoma haematobiumandSchistosoma mansonilinear B-cell epitopes with diagnostic potential usingin silicoimmunoinformatic tools and peptide microarray technology
  7. The association of systemic inflammation and cognitive functions of pre-school aged children residing in a Schistosoma haematobium endemic area in Zimbabwe
  8. Peptide microarray IgM and IgG screening of pre-SARS-CoV-2 human serum samples from Zimbabwe for reactivity with peptides from all seven human coronaviruses: a cross-sectional study
  9. Diagnostic performances of Schistosoma haematobium and Schistosoma mansoni recombinant proteins, peptides and chimeric proteins antibody based tests. Systematic scoping review
  10. Peptide microarray analysis of in-silico predicted B-cell epitopes in SARS-CoV-2 sero-positive healthcare workers in Bulawayo, Zimbabwe
  11. Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review
  12. Biochemical profile of paediatric adamantinomatous craniopharyngiomas: A prospective cohort study
  13. Helminth-HIV co-infection and malnutrition impact on immunity in Africa: dearth of empirical evidence
  14. Effect of Schistosoma haematobium infection on the cognitive functions of preschool age children and benefits of treatment from an endemic area in Zimbabwe
  15. Knowledge, attitudes, practices and behaviours (KAPB) around water, sanitation and hygiene (WASH) in villagers exposed to schistosomiasis in Zimbabwe
  16. Excessive neutrophil recruitment promotes typical T-helper 17 responses in Coronavirus disease 2019 patients
  17. Multiplex peptide microarray profiling of antibody reactivity against neglected tropical diseases derived B-cell epitopes for serodiagnosis in Zimbabwe
  18. Loss of regulation of complement C5 activation in HIV associated Preeclampsia
  19. Frequency distribution of cytokine and associated transcription factor single nucleotide polymorphisms in Zimbabweans: Impact on schistosome infection and cytokine levels
  20. Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment
  21. Screening of mushrooms from the woodlands of Zimbabwe: Occurrence of lectins and partial purification of a mucin specific lectin from Boletus edulis
  22. Scoping review of the applications of peptide microarrays on the fight against human infections
  23. Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers
  24. The Identification and Characterization of Immunoreactive Fungal Proteins Recognized by Sera from Zimbabweans Sensitized to Fungi
  25. Fungal allergic sensitisation in young rural Zimbabwean children: Gut mycobiome and seroreactivity characteristics
  26. Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates
  27. Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study
  28. Assessing early child development and its association with stunting and schistosome infections in rural Zimbabwean children using the Griffiths Scales of Child Development
  29. Algorithm for diagnosis of early Schistosoma haematobium using prodromal signs and symptoms in pre-school age children in an endemic district in Zimbabwe
  30. Clinical utility of peptide microarrays in the serodiagnosis of neglected tropical diseases in sub-Saharan Africa: protocol for a diagnostic test accuracy systematic review
  31. Interleukin-13 rs1800925/-1112C/T promoter single nucleotide polymorphism variant linked to anti-schistosomiasis in adult males in Murehwa District, Zimbabwe
  32. A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19
  33. Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
  34. Effects of TNF-α and IL-10-819 T>C single nucleotide polymorphisms on urogenital schistosomiasis in preschool children in Zimbabwe
  35. SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe
  36. Scoping review of the applications of peptide microarrays on the fight against human infections
  37. Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children
  38. Association of TNF (rs1800629) promoter polymorphism and schistosomiasis with sub‐microscopic asymptomaticPlasmodium falciparuminfections in a schistosomiasis‐endemic area in Zimbabwe
  39. Impact of Indolent Schistosomiasis on Morbidity and Mortality from Respiratory Tract Infections in Preschool Age Children from a Schistosomiasis Endemic Area
  40. Association of Schistosoma haematobium infection morbidity and severity on co-infections in pre-school age children living in a rural endemic area in Zimbabwe
  41. Association of schistosomiasis and risk of prostate cancer development in residents of Murehwa rural community, Zimbabwe
  42. Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
  43. Interleukin-10 and tumour necrosis factor alpha promoter region polymorphisms and susceptibility to urogenital schistosomiasis in young Zimbabwean children living in Schistosoma haematobium endemic regions
  44. Positive impact of preventative chemotherapy during a national helminth control program: Perception and KAP
  45. Immune response to asymptomatic infections by Entamoeba histolytica and other enteric pathogens in pregnant women and their infants in a high HIV burdened setting in Zimbabwe
  46. The Global Use of Mobile Based Applications in Tuberculosis (TB) Care: A Systematic Review Protocol
  47. Antimicrobial effects of craniopharyngioma cystic fluid
  48. Clinical morbidity associated with Schistosoma haematobium infection in pre‐school age children from an endemic district in Zimbabwe
  49. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe
  50. The gut microbiome but not the resistome is associated with urogenital schistosomiasis in preschool-aged children
  51. Inflammation during Schistosoma haematobium infection and anti‐allergy in pre‐school‐aged children living in a rural endemic area in Zimbabwe
  52. Barriers to Retention in HIV Infected Children on ART: Improvement Strategies at Kaduna State Comprehensive Health Care Facilities in Nigeria
  53. Elevation of C-reactive protein, P-selectin and Resistin as potential inflammatory biomarkers of urogenital Schistosomiasis exposure in preschool children
  54. The global burden of trichiasis in 2016
  55. In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination
  56. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
  57. Characterization of Anti-Salmonella typhi Compounds from Medicinal Mushroom Extracts from Zimbabwe
  58. Knock down and insecticidal activity of the plants Tagetes minuta, Lippia javanica, Lantana camara, Tagetes erecta and Eucalyptus grandis on Anopheles arabiensis mosquitoes
  59. In-depth proteomic characterization of Schistosoma haematobium: towards the development of new tools for elimination
  60. Endophytic fungi from Vitex payos: identification and bioactivity
  61. Endophytic Fungi Isolated from the Medicinal Plants Kigelia africana and Warburgia salutaris
  62. Drastic reduction in density of Blattella germanica and Periplaneta americana cockroaches after the application of fenitrothion and lindane in Dema, Zimbabwe
  63. The global burden of trichiasis in 2016
  64. Dynamics of paediatric urogenital schistosome infection, morbidity and treatment: a longitudinal study among preschool children in Zimbabwe
  65. Low IL-6, IL-10, and TNF-α and High IL-13 Cytokine Levels Are Associated with Severe Hepatic Fibrosis in Schistosoma mansoni Chronically Exposed Individuals
  66. Urogenital Schistosomiasis—Evidence-Based Benefits of Treatment Initiated Early During Childhood
  67. To what extent does salt (NaCl) affect Anopheles gambiae sensu lato mosquito larvae survival?
  68. Wound Healing Properties of Selected Plants Used in Ethnoveterinary Medicine
  69. Antioxidant properties, protein binding capacity and mineral contents of some plants traditionally used in the management of animal wounds
  70. Antibodies elicited during natural infection in a predominantly Plasmodium falciparum transmission area cross-react with sexual stage-specific antigen in P. vivax
  71. The Burden of and Risk Factors for Trachoma in Selected Districts of Zimbabwe: Results of 16 Population-Based Prevalence Surveys
  72. Comparison of the spatial patterns of schistosomiasis in Zimbabwe at two points in time, spaced twenty-nine years apart: is climate variability of importance?
  73. Putting the treatment of paediatric schistosomiasis into context
  74. The burden of worm infections in the control efforts
  75. Decrease in Seminal HIV-1 RNA Load After Praziquantel Treatment of Urogenital Schistosomiasis Coinfection in HIV-Positive Men—An Observational Study
  76. Inflammation-modulating cytokine profile and lipid interaction in HIV-related risk factors for cardiovascular diseases
  77. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe
  78. Effect of cooking and preservation on nutritional and phytochemical composition of the mushroom Amanita zambiana
  79. Seroepidemiology of Plasmodium species infections in Zimbabwean population
  80. Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children
  81. HIV-1 Disease Progression and Survival in an Adult Population in Zimbabwe: Is There an Effect of the Mannose Binding Lectin Deficiency?
  82. Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
  83. Of Monkeys and Men: Immunomic Profiling of Sera from Humans and Non-Human Primates Resistant to Schistosomiasis Reveals Novel Potential Vaccine Candidates
  84. Role of Mannose-Binding Lectin Deficiency in HIV-1 and Schistosoma Infections in a Rural Adult Population in Zimbabwe
  85. Group 2 Innate Lymphoid Cell Proportions Are Diminished in Young Helminth Infected Children and Restored by Curative Anti-helminthic Treatment
  86. Identifying and Evaluating Field Indicators of Urogenital Schistosomiasis-Related Morbidity in Preschool-Aged Children
  87. Down Regulation of the TCR Complex CD3ζ-Chain on CD3+ T Cells: A Potential Mechanism for Helminth-Mediated Immune Modulation
  88. Human parasitic protozoa in drinking water sources in rural Zimbabwe and their link to HIV infection
  89. Modelling climate change impact on the spatial distribution of fresh water snails hosting trematodes in Zimbabwe
  90. High Schistosoma mansoni Disease Burden in a Rural District of Western Zambia
  91. Distribution of Schistosomiasis and Soil Transmitted Helminthiasis in Zimbabwe: Towards a National Plan of Action for Control and Elimination
  92. CD16 Expression on Monocytes in Healthy Individuals but Not Schistosome-Infected Patients Is Positively Associated with Levels of Parasite-Specific IgG and IgG1
  93. Predicted Impact of Mass Drug Administration on the Development of Protective Immunity against Schistosoma haematobium
  94. Cytokine Responses to the Anti-schistosome Vaccine Candidate Antigen Glutathione-S-transferase Vary with Host Age and Are Boosted by Praziquantel Treatment
  95. Modelling spatial distribution of snails transmitting parasitic worms with importance to human and animal health and analysis of distributional changes in relation to climate
  96. Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes
  97. Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoniat the point-of-care in northeast Zimbabwe
  98. Maintaining respect and fairness in the usage of stored shared specimens
  99. Study participants incentives, compensation and reimbursement in resource-constrained settings
  100. Sources of heterogeneity in human monocyte subsets
  101. Soluble CD23 Levels are Inversely Associated with Atopy and Parasite-Specific IgE Levels but Not with Polyclonal IgE Levels in People Exposed to Helminth Infection
  102. Immunological Consequences of Antihelminthic Treatment in Preschool Children Exposed to Urogenital Schistosome Infection
  103. Viewpoint discrimination and contestation of ideas on its merits, leadership and organizational ethics: expanding the African bioethics agenda
  104. Chitinase 3-Like 1 Protein Levels Are Elevated in Schistosoma haematobium Infected Children
  105. Integrated Analysis of Innate, Th1, Th2, Th17, and Regulatory Cytokines Identifies Changes in Immune Polarisation Following Treatment of Human Schistosomiasis
  106. Age-Related Patterns in Human Myeloid Dendritic Cell Populations in People Exposed to Schistosoma haematobium Infection
  107. Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium
  108. Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti‐schistosome and anti‐mite antibodies
  109. High Seroprevalence of Enterovirus Infections in Apes and Old World Monkeys
  110. Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed toSchistosoma haematobium
  111. Atopy Is Inversely Related to Schistosome Infection Intensity: A Comparative Study in Zimbabwean Villages with Distinct Levels of Schistosoma haematobium Infection
  112. Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria
  113. Efficacy of integrated school based de-worming and prompt malaria treatment on helminths -Plasmodium falciparum co-infections: A 33 months follow up study
  114. Knowledge attitudes and practices of grade three primary schoolchildren in relation to schistosomiasis, soil transmitted helminthiasis and malaria in Zimbabwe
  115. Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
  116. Schistosome Infection Intensity Is Inversely Related to Auto-Reactive Antibody Levels
  117. Impaired allergy diagnostics among parasite-infected patients caused by IgE antibodies to the carbohydrate epitope galactose-α1,3-galactose
  118. Regulatory and Activated T Cells in Human Schistosoma haematobium Infections
  119. Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4
  120. Impact of Schistosome Infection on Plasmodium falciparum Malariometric Indices and Immune Correlates in School Age Children in Burma Valley, Zimbabwe
  121. The first community-based report on the effect of genital Schistosoma haematobium infection on female fertility
  122. Consequences of polyparasitism on anaemia among primary school children in Zimbabwe
  123. Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL‐5 and IL‐10 levels depend upon age and infection status
  124. Schistosomiasis PCR in Vaginal Lavage as an Indicator of Genital Schistosoma haematobium Infection in Rural Zimbabwean Women
  125. Downregulation of MIP-1α/CCL3 with praziquantel treatment in Schistosoma haematobiumand HIV-1 co-infected individuals in a rural community in Zimbabwe
  126. Impact of solar radiation in disinfecting drinking water contaminated withGiardia duodenalisandEntamoeba histolytica/disparat a point-of-use water treatment
  127. Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis
  128. Female genital schistosomiasis – a differential diagnosis to sexually transmitted disease: genital itch and vaginal discharge as indicators of genital Schistosoma haematobium morbidity in a cross‐sectional study in endemic rural Zimbabwe
  129. Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses
  130. The burden of polyparasitism among primary schoolchildren in rural and farming areas in Zimbabwe
  131. Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials : A proposal
  132. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe
  133. Age‐Related and Infection Intensity–Related Shifts in Antibody Recognition of Defined Protein Antigens in a Schistosome‐Exposed Population
  134. Prevention of Gynecologic Contact Bleeding and Genital Sandy Patches by Childhood Anti-schistosomal Treatment
  135. Entamoeba histolytica: Genetic diversity of African strains based on the polymorphism of the serine-rich protein gene
  136. Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age
  137. Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium
  138. Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter?
  139. Antibody responses to Plasmodium falciparum vaccine candidate antigens in three areas distinct with respect to altitude
  140. Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel
  141. Immuno-epidemiology of human Schistosoma haematobiuminfection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden
  142. Association between genital schistosomiasis and HIV in rural Zimbabwean women
  143. Praziquantel Treatment of Individuals Exposed toSchistosoma haematobiumEnhances Serological Recognition of Defined Parasite Antigens
  144. SIMPLE CLINICAL MANIFESTATIONS OF GENITAL SCHISTOSOMA HAEMATOBIUM INFECTION IN RURAL ZIMBABWEAN WOMEN
  145. Herpes simplex virus type 2 prevalence of epidemic proportions in rural Zimbabwean women: association with other sexually transmitted infections
  146. Understanding populations in endemic areas susceptible/resistance to infection
  147. Human papillomavirus in a rural community in Zimbabwe: The impact of HIV co‐infection on HPV genotype distribution
  148. Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area
  149. Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe
  150. Chemotherapy‐induced, age‐related changes in antischistosome antibody responses
  151. The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
  152. T cell clones from Schistosoma haematobium infected and exposed individuals lacking distinct cytokine profiles for Th1/Th2 polarisation
  153. The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
  154. Dissociation of interleukin‐4 and interleukin‐5 production following treatment for Schistosoma haematobium infection in humans
  155. Chemotherapy Accelerates the Development of Acquired Immune Responses toSchistosoma haematobiumInfection
  156. The impact of zinc supplementation on Schistosoma mansoni reinfection rate and intensities: A randomized, controlled trial among rural Zimbabwean schoolchildren
  157. The impact of zinc supplementation on growth and body composition: A randomized, controlled trial among rural Zimbabwean schoolchildren
  158. Ultrasonographic organometry: liver and spleen dimensions among children in Zimbabwe